Literature DB >> 22569043

Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.

Yongqian Bian1, Li Wang, Huanyu Lu, Guodong Yang, Zhang Zhang, Haiyan Fu, Xiaozhao Lu, Mengying Wei, Jianyong Sun, Qingchuan Zhao, Guanglong Dong, Zifan Lu.   

Abstract

Gastric cancer (GC) is the fourth most common cancer and second leading cause of cancer-related death worldwide. RNA-binding protein Quaking (QKI) is a newly identified tumor suppressor in multiple cancers, while its role in GC is largely unknown. Our study here aimed to clarify the relationship between QKI expression with the clinicopathologic characteristics and the prognosis of GC. In the 222 GC patients' specimens, QKI expression was found to be significantly decreased in most of the GC tissues, which was largely due to promoter hypermethylation. QKI overexpression reduced the proliferation ability of GC cell line in vitro study. In addition, the reduced QKI expression correlated well with poor differentiation status, depth of invasion, gastric lymph node metastasis, distant metastasis, advanced TNM stage, and poor survival. Multivariate analysis showed QKI expression was an independent prognostic factor for patient survival.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569043     DOI: 10.1016/j.bbrc.2012.04.138

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Primary analysis and screening of microRNAs in gastric cancer side population cells.

Authors:  Hai-Hong Zhang; Guo-Li Gu; Xiang-Yang Zhang; Feng-Zhi Li; Li Ding; Qin Fan; Ran Wu; Wei Shi; Xin-Yan Wang; Lin Chen; Xue-Ming Wei; Xiao-Ying Yuan
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.

Authors:  Takashi Shingu; Allen L Ho; Liang Yuan; Xin Zhou; Congxin Dai; Siyuan Zheng; Qianghu Wang; Yi Zhong; Qing Chang; James W Horner; Brandon D Liebelt; Yu Yao; Baoli Hu; Yiwen Chen; Gregory N Fuller; Roeland G W Verhaak; Amy B Heimberger; Jian Hu
Journal:  Nat Genet       Date:  2016-11-14       Impact factor: 38.330

3.  The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein.

Authors:  Yi Zhao; Gen Zhang; Mengying Wei; Xiaozhao Lu; Hanyan Fu; Feixue Feng; Shan Wang; Wei Lu; Ning Wu; Zifan Lu; Jianlin Yuan
Journal:  Cancer Biol Ther       Date:  2013-10-23       Impact factor: 4.742

4.  A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.

Authors:  Fernando J de Miguel; María J Pajares; Elena Martínez-Terroba; Daniel Ajona; Xabier Morales; Ravi D Sharma; Francisco J Pardo; Ana Rouzaut; Angel Rubio; Luis M Montuenga; Ruben Pio
Journal:  Mol Oncol       Date:  2016-08-09       Impact factor: 6.603

5.  RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.

Authors:  Rui-Li Zhang; Jun-Ping Yang; Li-Xia Peng; Li-Sheng Zheng; Ping Xie; Meng-Yao Wang; Yun Cao; Zhi-Ling Zhang; Fang-Jian Zhou; Chao-Nan Qian; Yong-Xing Bao
Journal:  Cell Cycle       Date:  2016-10-21       Impact factor: 4.534

6.  Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Giacomo Diaz; Marta Melis; Ashley Tice; David E Kleiner; Lopa Mishra; Fausto Zamboni; Patrizia Farci
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

7.  MiR-574-5p mediates the cell cycle and apoptosis in thyroid cancer cells via Wnt/β-catenin signaling by repressing the expression of Quaking proteins.

Authors:  Zhejia Zhang; Xinying Li; Qian Xiao; Zhiming Wang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

8.  An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer.

Authors:  Jiaxuan Liu; Ping Wang; Ping Zhang; Xinyu Zhang; Hang Du; Qiang Liu; Bo Huang; Caiyun Qian; Shuhua Zhang; Weifeng Zhu; Xiaohong Yang; Yingqun Xiao; Zhuoqi Liu; Daya Luo
Journal:  J Appl Genet       Date:  2019-08-01       Impact factor: 3.240

9.  Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.

Authors:  Liqiang Zhou; You Wu; Lin Xin; Qi Zhou; Shihao Li; Yiwu Yuan; Jinliang Wang; Dengzhong Wu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

10.  Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Rosa Berenato; Luca Turati; Alessia Mennitto; Francesca Steccanella; Marta Caporale; Pierpaolo Dallera; Filippo de Braud; Ezio Pezzica; Maria Di Bartolomeo; Giovanni Sgroi; Vincenzo Mazzaferro; Filippo Pietrantonio; Sandro Barni
Journal:  J Gastrointest Oncol       Date:  2017-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.